WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Efficacy Framework_v3, Baniff grade includes IB, Study treatments include Belatacept, Proteinurea may decrease Patient Survival, What are the efficacy points for prophylaxis of acute rejection in kidney transplant subject? are evaluated for Study treatments, Clinically suspected Acute Rejection can be defined by urine output, Graft Loss has Date of Graft Loss, Clinically suspected Acute Rejection can be defined by fever, Death can be recorded at Follow-up, Glomerular Filtration Rate (GFR) is measured as Decreased GFR, Death may result from PTLD (post-transplant lymphoproliferative disorder), defined timepoints is measured as increased, Treated BPAR episode treated with Anti-rejection therapy, Graft Loss is assessed as Withdrawl of Consent, BPAR (Biopsy Proven Acute Rejection) can result in Treated BPAR episode, Graft Loss is the inverse of Graft Survival, PTLD (post-transplant lymphoproliferative disorder) may affect Central Nervous System (CNS), Graft Loss is assessed as Nephrectomy, Acute Rejection Events consist of BPAR (Biopsy Proven Acute Rejection), BCAR (Biopsy Confirmed Acute Rejection) is assessed with Baniff grade, Renal function/Renal Impairment is assessed using Long Term Dialysis